Plasma Transfusion Process for Covid-19 as an Alternative Treatment | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Plasma Transfusion Process for Covid-19 as an Alternative Treatment

Author(s): Mohammad Asaduzzaman Chowdhury, Md. Ruhul Amin, Mohammod Abul Kashem, Md. Abdus Shahid and Nayem Hossain*

Plasma is the fluid in the body's blood. It contains proteins and other substances that are important for overall health. Plasma transfers are used for patients with liver failure, serious infections, and severe burns. The blood contains proteins called antibodies that can be developed by the immune system of recovered COVID-19 patients to fight the SARS-CoV-2 virus. The application of convalescent plasma was successful in the Spanish flu outbreaks in 1918. Subsequently, the success of applying convalescent plasma has also been found during the SARS epidemic of 2003, the influenza pandemic of 2009, and the latest Ebola epidemic in 2014. Currently, convalescent plasma therapy is in use for the COVID-19 epidemic. The hundred-year-old convalescent plasma therapy has been reported to reduce the mortality rate of coronavirus infections in Iran by 40%. This article can be a source of useful information about plasma therapy being used successfully for the treatment of COVID-19 infected patients worldwide.

Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry